NCT04712838

Study on the Bioavailability of SHR0302 in Healthy Subjects

Study on the Bioavailability of SHR0302 Tablets With 3 Different Formulations in Healthy Subjects (Single Center, Random, Open, 3 Cycles, 6 Sequences)

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 24 (actual)
• Sponsor: Jiangsu HengRui Medicine Co., Ltd. · Industry
• Sex: Male
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

The study is being conducted to evaluate the safety, and the relative bioavailability of SHR0302 tablets with three different formulations in healthy subjects.

Conditions

• Healthy Subjects

Interventions

Type	Name	Description
DRUG	SHR0302	Group A subjects were given oral F1 、F2 and F3 version SHR0302
DRUG	SHR0302	Group B subjects were given oral F1 、F3 and F2 version SHR0302
DRUG	SHR0302	Group C subjects were given oral F2 、F1 and F3 version SHR0302
DRUG	SHR0302	Group D subjects were given oral F2 、F3 and F1 version SHR0302
DRUG	SHR0302	Group E subjects were given oral F3 、F1 and F2 version SHR0302
DRUG	SHR0302	Group F subjects were given oral F3 、F2 and F1 version SHR0302

Timeline

• Start date: 2021-03-15
• Primary completion: 2021-04-13
• Completion: 2021-04-13
• First posted: 2021-01-15
• Last updated: 2021-10-20

Locations

1 site across 1 country: China